SCHEMBL4439128

SCHEMBL4439128

NC(=O)CCNC(=O)c1cnn2cc(Cc3ccc(Cl)c(OC(F)(F)F)c3)cnc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 5/20 0.48
KDM4A O75164 2/20 0.40
KDM5A P29375 2/20 0.40
PDE3A Q14432 1/20 0.38
PDE10A Q9Y233 1/20 0.38
IRAK4 Q9NWZ3 4/20 0.37
JAK2 O60674 1/20 0.36
JAK1 P23458 1/20 0.36
TYK2 P29597 1/20 0.36
JAK3 P52333 1/20 0.36
EPHX1 P07099 1/20 0.36
TRPV1 Q8NER1 1/20 0.35
RORC P51449 1/20 0.35
NR3C1 P04150 1/20 0.34
ALDH1A1 P00352 1/20 0.34
GPR52 Q9Y2T5 1/20 0.34
KDM4E B2RXH2 1/20 0.34
PKM P14618 1/20 0.34
HSD17B10 Q99714 1/20 0.34
AKT1 P31749 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4437022 0.91 PDE2A (0.50) PDE2AKDM4AKDM5APDE3APDE10A
SCHEMBL14033167 0.88 PDE2A (0.41) PDE2AIRAK4RORCKDM4EPKM
SCHEMBL14033706 0.85 GPR52 (0.41) PDE2APDE10AIRAK4JAK2GPR52
SCHEMBL14033150 0.85 KDM5A (0.53) PDE2AKDM4AKDM5APDE3APDE10A
SCHEMBL4434781 0.79 NR3C1 (0.47) PDE2AKDM4AKDM5AIRAK4TRPV1
SCHEMBL14033169 0.78 PDE2A (0.42) PDE2AIRAK4ALDH1A1KDM4EPKM
SCHEMBL4439750 0.76 PDE2A (0.41) PDE2APDE10AIRAK4GPR52KDM4E
SCHEMBL4555125 0.76 IRAK4 (0.43) PDE2AIRAK4JAK2KDM4EPKM
SCHEMBL14048912 0.76 PDE2A (0.44) PDE2APDE10AIRAK4KDM4EPKM
SCHEMBL14033688 0.75 PDE2A (0.46) PDE2AIRAK4ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137187-A1 PYRAZOLO [1,5-A]PYRIMIDINES AS INHIBITORS OF STEAROYL-COA DESATURASE Inovacia AB (SE) 2009-12-30 EP disclosed
US-20080255153-A1 New compounds BIOVITRUM AB (PUBL) (SE) 2008-10-16 US disclosed
US-20080255153-A1 New compounds BIOVITRUM AB (PUBL) (SE) 2008-10-16 US disclosed
WO-2008116898-A1 PYRAZOLO [1,5-A]PYRIMIDINES AS INHIBITORS OF STEAROYL-COA DESATURASE BIOVITRUM AB (PUBL) (SE) 2008-10-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255153-A1 New compounds SCD, SCD5, FADS2 PDE2A 2511/4885KDM4A 2198/4885KDM5A 1041/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.